Amplify Energy Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Amplify Energy Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $69.64M | Mar 14, 2019 |
| FY2018 | Sep 30, 2018 | $47.77M | Mar 14, 2019 |
| FY2018 | Jun 30, 2018 | $42.32M | Mar 14, 2019 |
| FY2018 | Mar 31, 2018 | $48.91M | Mar 14, 2019 |
| FY2018 | Dec 31, 2017 | $53.34M | Mar 14, 2019 |
| FY2018 | Sep 30, 2017 | $49.72M | Mar 14, 2019 |
| FY2018 | Jun 30, 2017 | $60.68M | Mar 14, 2019 |
| FY2018 | Mar 31, 2017 | $65.02M | Mar 14, 2019 |
| FY2018 | Dec 31, 2016 | $48.53M | Mar 14, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $263.36M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $294.68M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $307.60M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $458.46M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $342.92M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $202.14M | Mar 9, 2022 |
| FY2019 | Dec 31, 2019 | $77.93M | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $72.96M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $59.53M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $65.16M | Mar 5, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $53.34M | Mar 14, 2018 |
| FY2017 | Sep 30, 2017 | $49.72M | Mar 14, 2018 |
| FY2017 | Jun 30, 2017 | $60.68M | Mar 14, 2018 |
| FY2017 | Mar 31, 2017 | $65.02M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $48.53M | Mar 14, 2018 |
| FY2015 | Dec 31, 2015 | $365.15M | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $794.18M | Mar 30, 2016 |
| FY2015 | Dec 31, 2013 | $469.51M | Mar 30, 2016 |
| FY2014 | Dec 31, 2012 | $247.67M | Mar 16, 2015 |
| FY2013 | Dec 31, 2011 | $209.43M | Mar 24, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.97M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $12.95M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $392.75M | Apr 17, 2025 |
| FY2024 | Dec 31, 2022 | $57.88M | Apr 17, 2025 |
| FY2022 | Dec 31, 2021 | ($32.07M) | Mar 9, 2023 |
| FY2019 | Dec 31, 2019 | ($27.52M) | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $5.16M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $18.64M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | ($31.48M) | Mar 5, 2020 |
| FY2019 | Dec 31, 2018 | $79.25M | Mar 5, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.94M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $30.42M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $76.22M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $71.99M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($25.61M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($441.89M) | Mar 9, 2022 |
| FY2019 | Dec 31, 2019 | ($23.05M) | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $14.81M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $23.53M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | ($27.25M) | Mar 5, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.20M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $51.29M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $141.59M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $64.49M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $62.97M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $74.33M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $47.28M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $141.78M | Mar 5, 2020 |
| FY2019 | Dec 31, 2017 | $94.64M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $23.64M | Mar 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $600.90M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $747.08M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $737.67M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $459.48M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $455.10M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $384.76M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $877.54M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $836.84M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $688.13M | Mar 14, 2019 |
| FY2019 | May 4, 2017 | $981.43M | Mar 5, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $142.18M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $338.16M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $346.64M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $464.04M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $519.94M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $418.50M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $443.33M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $420.29M | Mar 5, 2020 |
| FY2019 | May 4, 2017 | $591.29M | Mar 5, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $458.72M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $408.91M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $391.04M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | ($4.57M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($64.84M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | ($33.74M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $434.21M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $416.56M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $393.93M | Mar 5, 2020 |
| FY2019 | May 4, 2017 | $390.14M | Mar 5, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.50M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($31.47M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | ($44.45M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($437.20M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($495.08M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($463.01M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $4.81M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $55.90M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($75.15M) | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $9.93M | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.67M | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $20.75M | Mar 5, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Mar 9, 2023 |
| FY2022 | Dec 31, 2021 | $18.80M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $10.36M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $49.70M | Mar 5, 2020 |
| FY2019 | Dec 31, 2017 | $6.39M | Mar 5, 2020 |
| FY2019 | May 4, 2017 | $20.14M | Mar 5, 2020 |
| FY2017 | Dec 31, 2016 | $76.84M | Mar 14, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $190.00M | Mar 9, 2023 |
| FY2022 | Dec 31, 2021 | $230.00M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $260.52M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $285.00M | Mar 11, 2021 |
| FY2016 | Dec 31, 2016 | $128.06M | Mar 30, 2017 |
| FY2015 | Dec 31, 2015 | $1.89B | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $1.71B | Mar 30, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 9 | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | (12) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | (1) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 2 | Mar 5, 2020 |
| FY2019 | Dec 31, 2017 | 0 | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 14, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | 9 | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | (12) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | (1) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 2 | Mar 5, 2020 |
| FY2019 | Dec 31, 2017 | 0 | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 14, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40.72M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 39.80M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | 39.15M | Mar 9, 2026 |
| FY2023 | Dec 31, 2022 | 38.46M | Mar 7, 2024 |
| FY2021 | Dec 31, 2021 | 38.02M | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | 37.66M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | 37.57M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 22.18M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | 25.17M | Mar 14, 2019 |
| FY2019 | May 4, 2017 | 25.00M | Mar 5, 2020 |